首页> 美国卫生研究院文献>ISRN Dentistry >Comparison of Titratable Oral Appliance and Mandibular Advancement Splint in the Treatment of Patients with Obstructive Sleep Apnea
【2h】

Comparison of Titratable Oral Appliance and Mandibular Advancement Splint in the Treatment of Patients with Obstructive Sleep Apnea

机译:可滴定的口腔矫治器和下颌前倾夹板治疗阻塞性睡眠呼吸暂停的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective. To compare the effect of two intraoral devices (titratable oral appliance-Klearway (KW) and mandibular advancement splint (MAS)) in mild and moderate obstructive sleep apnea (OSA) patients. Method and Materials. The study group was comprised of twenty-four adult volunteer patients with OSA. Twelve subjects were fitted with a titratable oral appliance (group KW) protruding the mandible (85% of maximum protrusion). The other 12 subjects received MAS with 75% protrusion of the mandible (group MAS). Baseline, (“0.PSG”), first week (K1.PSG for KW group and M1.PSG for MAS group), and after the first month (K2.PSG for KW group and M2′. PSG for MAS group). Results. Both groups produced similar reduction in apnea-hypopnea index (AHI) from baseline till the end of the first week and first month (P < .05). However, the success rate of both groups at the end of the first month was found to be statistically different from the success rate of the first week (P < .05). The reduction in mean AHI of group KW-moderate (KW-mo) was significantly different from the mean AHI of group MAS-moderate (MAS-mo) at the end of the first month (P < .05). Conclusion. This study suggests that Klearway appliance was more effective in treating moderate OSA patients than MAS appliance. It was concluded that an appliance that provides 85% mandibular advancement to open the upper airway was more effective in reducing the number of high apneic events during sleep in comparison to the one which provides 75%.
机译:目的。为了比较两种口内装置(可滴定的口腔器具-Klearway(KW)和下颌前移夹板(MAS))在轻度和中度阻塞性睡眠呼吸暂停(OSA)患者中的作用。方法和材料。该研究组由二十四名成人OSA志愿者组成。 12位受试者装有可滴定的口腔器具(KW组),使下颌骨突出(最大突出量的85%)。其他12名受试者接受MAS,其下颌骨突出率为75%(MAS组)。基线(“ 0.PSG”),第一周(KW组为K1.PSG,MAS组为M1.PSG),第一个月之后(KW组为K2.PSG,MAS组为M2'.PSG)。结果。从基线到第一周和第一个月末,两组的呼吸暂停低通气指数(AHI)均降低(P <.05)。但是,发现两组在第一个月末的成功率与第一周的成功率有统计学差异(P <.05)。在第一个月末,KW中度组(KW-mo)的平均AHI降低与MAS中度组(MAS-mo)的平均AHI显着不同(P <.05)。结论。这项研究表明,Klearway矫治器在治疗中度OSA患者方面比MAS矫治器更为有效。结论是,与提供75%的设备相比,提供85%的下颌前移来打开上呼吸道的设备在减少睡眠期间高呼吸暂停事件的次数方面更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号